NPI registry status
Active
2026 NPPES data Otolaryngic Allergy Physician NPI 1528012655 M.D.
Verify on CMS → Mark Montgomery, M.D.
Otolaryngic Allergy Physician in Bonita Springs, Florida.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 151 in Otolaryngic Allergy Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
954
Medicare Part D claims · 364 beneficiaries · Otolaryngic Allergy Physician avg: 788
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · Above neutral
Industry payments
$2.6K
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Mark Montgomery, M.D. reported a CMS MIPS final score of 75/100 - below the 83.1 national average - and filed 954 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 954
- Part D claims, 2023
- 94%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Mark Montgomery, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mark Montgomery, M.D. sits
This provider among otolaryngic allergy physician peers
Across the 63 otolaryngic allergy physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mark Montgomery, M.D. writes more Part D claims than 59% of them and scores higher on MIPS quality than 22% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one otolaryngic allergy physician peer from a representative sample of 60; the gold marker is Mark Montgomery, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Mark Montgomery, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mark Montgomery, M.D.?
Below national averagePrimary specialty
Otolaryngic Allergy Physician
Medicare Part D claims
954 21% vs specialty avg
MIPS final score
75/100 8.1 pts vs avg
Specialty distribution in Florida
How Otolaryngic Allergy Physician compares to other specialties among Florida providers
Medicare quality performance, MIPS
Mark Montgomery, M.D.'s 2023 MIPS final score plotted against the Otolaryngic Allergy Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Otolaryngic Allergy Physician) - 75/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Mark Montgomery, M.D. appears in the CMS NPPES registry as an Otolaryngic Allergy Physician provider holding M.D. credentials at 9240 BONITA BEACH RD SE STE 1106, Bonita Springs, FL, 34135, with a listed phone of (239) 495-6200. NPI 1528012655 was issued on 05/22/2006.
Medicare Part D records for calendar year 2023 show 954 prescription claims written by this provider, covering 364 Medicare beneficiaries and totaling roughly $80K in drug spend, split 6% brand-name and 94% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Otolaryngic Allergy Physician is a narrow specialty nationwide, with 151 enrolled providers across 38 states and an average of 788 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1528012655 |
|---|---|
| Specialty | Otolaryngic Allergy Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 05/22/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
75
Final Score
Avg: 83.1
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Mark Montgomery, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$2.6K
Largest payer
Medtronic, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Florida FLDOH 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 - they are NOT specific to Mark Montgomery, M.D.. To verify Mark Montgomery, M.D.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases
FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
Mark Montgomery, M.D. - brand share 6.0%
Otolaryngic Allergy Physician average
6% brand-name claims vs 94% generic, on 954 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
954
Total Claims
$80K
Total Drug Cost
364
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,786
- Total Day Supply
- 49,504
- Brand vs Generic
- 6% brand / 94% generic
- Brand Drug Cost
- $49K
- Generic Drug Cost
- $31K
- Antibiotic Claims
- 50
Patient Demographics
- Average Patient Age
- 77.5 years
- Avg HCC Risk Score
- 1.15
- Gender Split
- 54% female / 46% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mark Montgomery, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Azelastine Hcl
Azelastine Hcl
177 claims
- Famotidine
Famotidine
139 claims
- Omeprazole
Omeprazole
128 claims
- Montelukast Sodium
Montelukast Sodium
88 claims
- Ipratropium Bromide 57
Ipratropium Bromide
57 claims
- Fluticasone Propio… 38
Fluticasone Propionate
38 claims
- Clotrimazole-Betam… 33
Clotrimazole-Betamethasone
33 claims
- Pantoprazole Sodium 32
Pantoprazole Sodium
32 claims
| Drug | Claims |
|---|---|
| Azelastine Hcl | 177 |
| Famotidine | 139 |
| Omeprazole | 128 |
| Montelukast Sodium | 88 |
| Ipratropium Bromide | 57 |
| Fluticasone Propionate | 38 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 33 |
| Pantoprazole Sodium | 32 |
| Neomycin-Polymyxin-Hydrocort Neomycin/Polymyxin B/Hydrocort | 27 |
| Cefdinir | 26 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Otolaryngic Allergy Physician Overview
How Mark Montgomery, M.D. fits within the Otolaryngic Allergy Physician landscape nationally.
151
Otolaryngic Allergy Physician Providers in US
38
States with Otolaryngic Allergy Physician
788
Avg Claims per Provider
Mark Montgomery, M.D.'s 954 claims are above the specialty average of 788.
Nearby Otolaryngic Allergy Physician Providers in Florida
Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as Montgomery.
Dr. Richard Allen
MD
Fort Pierce, FL
Dr. Joseph Bradfield
M.D.
Winter Haven, FL
Dr. Charles Brooker
M.D.
Winter Haven, FL
Dr. Angelo Consiglio
MD
Marianna, FL
Dr. Cecelia Damask
DO
Orlando, FL
Compare Otolaryngic Allergy Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Florida medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Otolaryngic Allergy Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Florida
Frequently Asked Questions
What is Mark Montgomery, M.D.'s specialty? ▼
Mark Montgomery, M.D. specializes in Otolaryngic Allergy Physician and practices in Bonita Springs, Florida. Credentials: M.D..
How much does Mark Montgomery, M.D. prescribe under Medicare Part D? ▼
In 2023, Mark Montgomery, M.D. wrote 954 Medicare Part D claims totaling $80K in drug costs for 364 beneficiaries.
What is Mark Montgomery, M.D.'s Medicare quality score? ▼
Mark Montgomery, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Mark Montgomery, M.D. located? ▼
Mark Montgomery, M.D. is located at 9240 BONITA BEACH RD SE STE 1106, Bonita Springs, FL, 34135. Phone: (239) 495-6200.
What is Mark Montgomery, M.D.'s NPI number? ▼
Mark Montgomery, M.D.'s National Provider Identifier (NPI) is 1528012655, issued on 05/22/2006.
Does Mark Montgomery, M.D. prescribe more brand-name or generic drugs? ▼
Mark Montgomery, M.D.'s prescribing is 6% brand-name and 94% generic drugs by claim count, with $49K in brand drug costs.
How many Otolaryngic Allergy Physician providers are there in the US? ▼
There are 151 Otolaryngic Allergy Physician providers across 38 states in the US. The average Otolaryngic Allergy Physician provider writes 788 Medicare Part D claims per year.
What drugs does Mark Montgomery, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Mark Montgomery, M.D.'s most frequently prescribed drugs include Azelastine Hcl, Famotidine, Omeprazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Mark Montgomery, M.D. accept Medicare? ▼
Mark Montgomery, M.D. appears in CMS Medicare data with 954 Part D claims and 364 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Mark Montgomery, M.D.'s credentials? ▼
Mark Montgomery, M.D.'s NPI is 1528012655 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.